AUSTIN, Texas--(BUSINESS WIRE)-- Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapies for cancer, announced that new preclinical data from its lead therapeutic program will be presented this week at two different conferences: 2012 TIDES Oligonucleotide and Peptide Research, Technology, and Product Development Conference in Las Vegas, Nevada, and the 2012 European Microsymposium on Small RNAs in Basel, Switzerland.
